Evidence map›Paper›PMID 24646489›Full record

Trial reportStem cells translational medicine2014

Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Hong-Kee Tan, Cheng-Xu Delon Toh, Dongrui Ma, Binxia Yang, Tong Ming Liu, Jun Lu, Chee-Wai Wong, Tze-Kai Tan, Hu Li, Christopher Syn and 5 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Stem cells translational medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Hong-Kee TanEpigenetics and Cell Fates Laboratory, A*STAR Institute of Molecular and Cell Biology, Singapore; Research and Development Unit, National Heart Centre Singapore, Singapore; Stem Cell and Developmental Biology, Genome Institute of Singapore, and Bioinformatics Institute, A*STAR, Singapore; Center for Individualized Medicine, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA; Health Sciences Authority, Singapore; Centre for Biomedical and Life Sciences, Singapore Polytechnic, Singapore; Department of Paediatrics, University Children's Medical Institute, National University Hospital, Singapore; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; Department of Biochemistry, Yong Loo Lin School of Medicine, Department of Biological Sciences, and NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore; Duke-NUS Graduate Medical School, Singapore; Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom.
Cheng-Xu Delon Toh
Dongrui Ma
Binxia Yang
Tong Ming Liu
Jun Lu
Chee-Wai Wong
Tze-Kai Tan
Hu Li
Christopher Syn
Eng-Lee Tan
Bing Lim
Yoon-Pin Lim
Stuart A Cook
Yuin-Han Loh
Agency for Science, Technology and Research · SGInstitute of Molecular and Cell Biology · SGNational Heart Centre Singapore · SGNational University of Singapore · SGDuke-NUS Medical School · SGGenome Institute of Singapore · SGHarvard University · USMayo Clinic · USSingapore Polytechnic · SG

Funding

Medical Research Council MC_U120085815
6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs) derived from somatic cells of patients can be a good model for studying human diseases and for future therapeutic regenerative medicine. Current initiatives to establish human iPSC (hiPSC) banking face challenges in recruiting large numbers of donors with diverse diseased, genetic, and phenotypic representations. In this study, we describe the efficient derivation of transgene-free hiPSCs from human finger-prick blood. Finger-prick sample collection can be performed on a "do-it-yourself" basis by donors and sent to the hiPSC facility for reprogramming. We show that single-drop volumes of finger-prick samples are sufficient for performing cellular reprogramming, DNA sequencing, and blood serotyping in parallel. Our novel strategy has the potential to facilitate the development of large-scale hiPSC banking worldwide.

Indexed as

Biological Specimen BanksFemaleFingersHumansInduced Pluripotent Stem CellsMaleRegenerative MedicineSpecimen HandlingFinger prickHuman induced pluripotent stem cell bankingHuman peripheral bloodInduced pluripotent stem cellsReprogramming

Identifiers

PMID24646489
PMCPMC4006490
OpenAlexW2162561482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.